PI
ACOR

PineBridge Investments’s Acorda Therapeutics ACOR Stock Holding History

PineBridge Investments’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-28
Closed -$44K – 1151
2019
Q1 		$44K Sell
28
-351
-93% -$632K ﹤0.01% 942
2018
Q4 		$709K Sell
379
-179
-32% -$390K 0.02% 603
2018
Q3 		$1.32M Sell
558
-104
-16% -$322K 0.02% 520
2018
Q2 		$2.28M Buy
662
+1
+0.2% +$3.06K 0.06% 330
2018
Q1 		$1.88M Sell
661
-7
-1% -$21K 0.04% 382
2017
Q4 		$1.72M Buy
668
+102
+18% +$290K 0.04% 411
2017
Q3 		$1.61M Sell
566
-60
-10% -$158K 0.04% 373
2017
Q2 		$1.48M Buy
626
+576
+1,152% +$1.14M 0.04% 363
2017
Q1 		$127K Buy
50
+1
+2% +$2.88K ﹤0.01% 879
2016
Q4 		$111K Hold
49
– – ﹤0.01% 959
2016
Q3 		$122K Hold
49
– – 0.01% 703
2016
Q2 		$149K Buy
49
+2
+4% +$6.5K 0.01% 620
2016
Q1 		$148K Sell
47
-1
-2% -$4.15K 0.01% 589
2015
Q4 		$248K Buy
48
+3
+7% +$13.1K 0.01% 450
2015
Q3 		$144K Buy
45
+4
+10% +$15.5K 0.01% 629
2015
Q2 		$164K Sell
41
-50
-55% -$193K 0.01% 565
2015
Q1 		$363K Buy
91
+12
+15% +$55K 0.01% 538
2014
Q4 		$388K Buy
79
+3
+4% +$12.9K 0.01% 468
2014
Q3 		$307K Buy
76
+23
+43% +$86.3K 0.01% 495
2014
Q2 		$215K Sell
53
-33
-38% -$135K 0.01% 530
2014
Q1 		$391K Sell
86
-8
-9% -$32.3K 0.01% 516
2013
Q4 		$331K Buy
94
+56
+147% +$218K 0.01% 603
2013
Q3 		$157K Hold
38
– – ﹤0.01% 564
2013
Q2 		$151K Buy
+38
New +$156K ﹤0.01% 562

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PineBridge Investments's ACOR Position: Q2 2019 in Review

PineBridge Investments sold out of Acorda Therapeutics (ACOR) in Q2 2019, closing a stake of 28 shares — an estimated $44K sold.

PineBridge Investments first reported a position in ACOR in Q2 2013 and held it in 24 quarters. The position peaked at $2.28M in Q2 2018. 163 funds tracked by Wall St. Rank hold ACOR as of Q2 2019.

  • PineBridge Investments reported no remaining Acorda Therapeutics position as of Q2 2019 after selling out during the quarter.
  • PineBridge Investments sold 28 Acorda Therapeutics shares in Q2 2019, an estimated $44K.
  • PineBridge Investments first reported a position in Acorda Therapeutics in Q2 2013 and held it in 24 quarters.
  • PineBridge Investments's Acorda Therapeutics position peaked at $2.28M in Q2 2018.
  • 163 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2019.

Based on PineBridge Investments's 13F filing for Q2 2019, filed 13 Aug 2019.